A
Applaud Medical
Developed an innovative new treatment for kidney stones designed to accelerate and amplify the fragmentation process, providing faster procedures and better patient outcomes
About Applaud Medical
Avvio Medical is at the forefront of enhancing the standard of care for patients suffering from urinary stone disease. The company is pioneering a novel office-based procedure that aims to reduce wait times and eliminate the need for fluoroscopy or general anesthesia, thereby significantly lowering overall medical costs. Although Avvio Medical does not currently offer medical devices for sale or distribution, and its technology has not yet received market clearance from the U.S. FDA or any other regulatory authority, the company is dedicated to providing the safest and most effective treatments for harmful biomineralization and urinary stone disease. The company operates in the healthcare sector, specifically targeting patients with urinary stone disease. Its business model revolves around developing and eventually commercializing innovative medical technologies that improve patient outcomes and reduce healthcare costs. Revenue generation is anticipated through the sale and distribution of these medical devices once regulatory approvals are obtained.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- San Francisco, United States
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 70.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Non-Invasive medical devices and treatments, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Aug 2022 | $16M | $64M | Undisclosed | ↗ |
| SERIES BEquity / VC | Oct 2021 | $7.1M | $28M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Applaud Medical is 1.4K monthly website visits, down 60% over the last three months. Applaud Medical's team declined 3.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 Sinaptica TherapeuticsClinical-stage company that has developed a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease |
Cambridge, United States | Operational | 19 | — | — |
 GelmetixInjectable polymer gel for non-surgical chronic pain treatment |
London, United Kingdom | Operational | |||
 ScribensDevelopment of non-invasive tools for early detection and follow-up of neurological dysfunctions |
Montreal, Canada | Closed | |||
 CroivalveTreating Heart Valve Disease |
Dublin, Ireland | Operational | |||
 Stayble TherapeuticsNew treatment for chronic back pain |
Göteborgs Stad, Sweden | Operational | |||
 Leuko LabsDeveloping the first device for non-invasive white cell monitoring |
Boston, United States | Operational | |||
 SonomotionDeveloping Innovations in Non-Invasive Kidney Stone Treatment |
San Francisco, United States | Operational | |||
 Damae MedicalMedical device capable of seeing biological tissues in depth, at a cellular level and in vivo |
Paris, France | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors10 additional known investors
Ben-Gurion University of the Negev
Baruch Future Ventures
Berkeley Catalyst Fund- CFCloudstone Venture Fund
- CVConstellar Ventures
KCK MedTech
MBC Biolabs
Mission BioCapital
SVE Capital
William Hyun
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Applaud Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Applaud Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.